🔎 Trials Near Me

Beranda › Diabetes Tipe 2 › Georgia

Uji klinis Diabetes Tipe 2 di Georgia

34 studi untuk Diabetes Tipe 2 mencari peserta di lokasi di Georgia.

Kota di Georgia

Teks studi resmi (Bahasa Inggris)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Centricity Research, Endocrine Consultants, Columbus
  • Javara-Fayetteville-67354, Fayetteville
  • Balanced Life Health Care Solutions, Lawrenceville
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Centricity Research, Endocrine Consultants, Columbus
  • NSC Research Inc, Johns Creek
  • The Jones Center Clinical Research, LLC, Macon
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • North Georgia Clinical Research, Woodstock
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Aiyan Diabetes Center, Augusta
  • Emory University, Dunwoody
  • Privia Medical Group Georgia LLC -Fayetteville (Javara), Fayetteville
  • dan 7 lainnya
Menerima pesertaSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06112418

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Stockbridge
  • Research Site, Woodstock
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Teak Research Consults - Dunwoody, Dunwoody
  • Teak Research Consults, Lawrenceville
  • The Jones Center Clinical Research, Macon
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Woodstock
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Canton
  • AURORA-2 Clinical Site, Decatur
  • AURORA-2 Clinical Site, Union City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Privia Medical Group Georgia, LLC - Albany - Javara - PPDS, Albany
  • Javara Inc. - Fayetteville, Fayetteville
  • Privia Medical Group Georgia, LLC - Savannah - Javara - PPDS, Savannah
  • dan 1 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Centricity Research Columbus Georgia Multispecialty, Columbus
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
  • Physicians Research Associates, Lawrenceville
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
  • dan 1 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06897475

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Privia Medical Group of Georgia, LLC, Savannah
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Columbus Research Foundation, Columbus
  • Eastside Bariatric and Gen Surg, Snellville
Menerima pesertaFase 3
Usia 10 hingga 18 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Emory University School of Medicine, Atlanta
  • IACT Health-Brookstone Centre Pkwy, Columbus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • SKY Clinical Research Network Group-Brown, Atlanta
  • Teak Research Consults, Lawrenceville
  • AGILE Clinical Research Trials, LLC, Sandy Springs
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07215559

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

  • Georgia State University, Atlanta
Menerima peserta
Usia 20 hingga 65 · Wanita · Diperbarui 2 Sep 2026 · NCT06735651

Peanuts for Cardiometabolic, Brain, and Intestinal Health

  • Georgia State University, Atlanta
Menerima peserta
Usia 20 hingga 59 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06867198

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Javara/Privia Med Grp GA,LLC, Albany
  • David Kavtaradze MD, Inc., Cordele
  • Atlanta Heart Specialist, Tucker
Menerima pesertaFase 3
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Conyers
  • Research Site, Decatur
  • Research Site, Hinesville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07662044

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Atlanta
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07662109

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

  • Research Site, Decatur
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Centricity Research IRT - DBA IACT Health Columbus Piedmont, Columbus
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07527650

Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management

  • Emory Healthcare, Atlanta
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07474376

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
  • Centricity Research Columbus Endocrinology, Columbus
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06739122

Families Implementing Good Health Traditions for Life

  • Morehouse School of Medicine, Albany
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07441655

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

  • Research Site, Decatur
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07664553

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • EMORY, Atlanta
  • Atlanta Diabetes Associates, Atlanta
  • Endocrine Research Solutions, Inc., Rosewell
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07521475

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Emory University, Atlanta
Menerima peserta
Usia 14 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07579702

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

  • Grady Memorial Hospital, Atlanta
Menerima pesertaFase 3
Usia 65 ke atas · Wanita · Diperbarui 3 Agu 2026 · NCT07428746

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT06699810

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • David Kavtaradze MD, Inc, Cordele
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • David Kavtaradze MD InC, Cordele
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT07546929

Mobile App Logging for Diabetes in Pregnancy

  • Augusta University, Augusta
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 100 · Wanita · Diperbarui 31 Jan 2025 · NCT06005987

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.